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Seven laboratories participated in a collaborative study to In 1954, Schneierson (9) described a rapid (4 to 6 h) drug susceptibility test in which prepared disks of known antimicrobial content were used to provide specific drug concentrations in tubes of broth. This approach has been used in at least two automated systems, of which Autobac 1 is one (5, 6, 8, 12) .
The present report presents the results of a collaborative study designed to compare the Autobac 1 system, the Bauer-Kirby disk diffusion test, and an agar dilution technique.
MATERIALS AND METHODS
Reagents and media. Identical lots of media, disks, and antimicrobial agents were used in the susceptibility tests performed in each laboratory. The media used were tryptic soy agar, tryptic soy broth, Mueller-Hinton agar, and Eugonic broth, all manufactured by Pfizer Diagnostics and supplied by this firm to the investigators. The antimicrobial drug-con- ' Present address: University of Utah, Salt Lake City, Utah 84132. 2Present address: University of Minnesota, Minneapolis, Minn. 55455. taining disks used in the Autobac 1 system (Table 1) , and those used in the agar diffusion tests (Table 2), were also manufactured by Pfizer, Inc. However, in our study, some Pseudomonas aeruginosa strains were also tested with carbenicillin diffusion disks from Baltimore Biological Laboratories (BBL; Cockeysville, Md.). Antimicrobial powders that were used in the agar dilution susceptibility tests (Table 2) were either Pfizer products or were obtained from other manufacturers by Pfizer for use in these studies.
Organisms. The organisms used in the study were current isolates from the clinical laboratories associated with the seven groups of investigators. The organisms were isolated and stored on media in routine use in each laboratory. For susceptibility testing, the organisms were streaked onto tryptic soy agar containing 5% sheep blood; cultures received from other laboratories were subcultured twice on this medium prior to testing. Three control cultures were used throughout the study; two of them were the "Seattle" Escherichia coli (derived from ATCC 25922) and Staphylococcus aureus (derived from ATCC 25923) strains recommended by the Food and Drug Administration and the third was the "Mayo" strain of P. aeruginosa. (ii) Diffusion method. The standardized disk agar diffusion method used in these studies was the Food and Drug Administration procedure (4) derived from the Bauer-Kirby procedure (1), as expanded in the tentative report of the National Committee for Clinical Laboratory Standards (7) . The tests were performed as outlined by the National Committee for Clinical Laboratory Standards.
(iii) Autobac 1. The Autobac 1 ( Fig. 1) is an instrument which utilizes forward light scattering to detect the effects of antimicrobial agents on the proliferation of bacteria in broth (6, 8) . The system consists of four components: (i) a transparent, plastic, multichambered cuvette in which an inoculum is automatically distributed to 12 test chambers and one control chamber, and into which the antimicrobial agents are delivered on paper disks; (ii) an incubatorshaker, which incubates the cuvette at 35 C and agitates it for 3 h; (iii) a disk dispenser which loads the cuvettes with the panel of elution disks; and (iv) an automated light-scattering photometer, which standardizes the inoculum, reads the amount of growth in each chamber of the cuvette, automatically compares the amount of growth in the presence of an antimicrobial agent to the amount of growth in the control, and prints out a numerical ratio between 0 and 1, called a light-scattering index (LSI) (8) .
Morphologically similar colonies were picked from the tryptic soy agar plate and transferred to optically clear, buffered saline supplied for use with Autobac 1. Each saline inoculum was vortexed to achieve an even suspension of organisms and was placed into the standardization port of the Autobac 1 photometer, adjusted if necessary to yield a turbidity which had been shown to equate to 107 to 2 x 107 CFU/ml, diluted in optically clear, sterile Eugonic broth (Pfizer), to give a tenfold dilution of the inoculum. (The one exception to this dilution protocol was that for Pseudomonas strains, where a 1:50 dilution was used.) The broth inoculum was then distributed into cuvettes and antimicrobial elution disks were added. The cuvettes were then placed in the incubatorshaker at 35 C, and at the end of 3 h, each cuvette was placed in the photometer where the light-scatter reading for each chamber was automatically measured and recorded. Comparison of the light scatter reading for each drug concentration was compared to that of the growth control and was recorded as a ratio. (The LSI indicated the extent of inhibition of growth by the antimicrobial agent in each of the chambers.) The susceptibility interpretations of the LSI are shown in Table 2 .
Collaborative study. Protocol and methods. The methods and protocol were agreed upon by the collaborators, each of whom was asked to follow them exactly. The collaborative study involved three phases. In Phase 1, each of the seven collaborators performed both the disk diffusion and Autobac 1 tests simultaneously on 300 bacterial strains isolated in their respective laboratories. The number of each species used in these studies was determined by the frequency with which they had been encountered in clinical specimens in the six clinical centers involved in the study. The strains used by the seventh investigator (Center for Disease Control, Atlanta) were obtained from the Veterans' Administration Hospital in Atlanta, Ga. Each laboratory kept all its strains in stock culture, and data on strain identification, zone diameter, and LSI were recorded and collated centrally. Gram-positive bacterial isolates were tested with cephalothin, clindamycin, erythromycin, gentamicin, methicillin, penicillin G, tetracycline, and vancomycin. Gram-negative isolates from the urinary tract were tested with ampicillin, carbenicillin, cephalothin, gentamicin, nalidixic acid, nitrofurantoin, and tetracycline. Other gram-negative isolates were tested with ampicillin, carbenicillin, caphalothin, chloramphenicol, colistin, gentamicin, kanamycin, polymyxin B, and tetracycline.
In Phase 2, each collaborator performed agar dilution tests with four to six antimicrobial agents against the appropriate species among his 300 bacterial isolates. It was not practical for each collaborator to perform the agar dilution test for all antimicrobial agents. However, the protocol was so designed that at least two collaborators performed agar dilution tests with each given antimicrobial agent. Phase 2 provided data for comparing interpretive agreement between Autobac 1 and the dilution tests, and between the diffusion and the dilution tests. Each time tests were FIG. 1. Components of the Autobac 1 system: 1, 13-chambered cuvette; 2, antimicrobic disk dispenser; 3, incubator/shaker; and 4, light-scattering photometer.
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on October 25, 2017 by guest http://aac.asm.org/ performed, standard reference strains were also tested. These strains were those mentioned previously, E. coli (ATCC 25922), S. aureus (ATCC 25923), and P. aeruginosa (Mayo strain). Two of the laboratories had been using the P. aeruginosa strain as a control strain for one or more years. Results obtained with these control cultures were used to determine if the tests were "under control."
In Phase 3, 70 bacterial strains were tested simultaneously by each investigator by the Autobac 1, disk diffusion and agar dilution techniques (in the last mentioned, only the assigned antimicrobial agents were used). Sixty of the 70 strains were randomly selected by computer, 10 from each of the six clinical centers. The remaining 10 isolates were purposely selected from the Center for Disease Control collection because of their unusual characteristics.
The 10 isolates from each clinical center included one each of the following 10 groups of organisms: E. coli. P. aeruginosa, Klebsiella sp., Enterobacter sp., Proteus mirabilis, Proteus sp. (indole +), Serratia sp., enterococcus, S. aureus (penicillin susceptible), S. aureus (penicillin resistant). All isolates were collected, recoded, and redistributed to all collaborators by C. Thornsberry at the Center for Disease Control. Although Phase 3 primarily provided the opportunity for interlaboratory analysis of reproducibility for the disk diffusion and Autobac 1 tests, it also provided a measure of intralaboratory reproducibility of these tests. Reproducibility was determined both quantitatively (as variation in zone diameter or LSI) and qualitatively (as variation in interpretive category). Further analysis also produced a measure of the equivalence of the two test methods, as indicated by frequency of agreement between the two techniques on a particular interpretive category (susceptible, intermediate, or resistant).
Intralaboratory reproducibility was measured quantitatively by estimating the standard deviation (6) from the within-laboratory differences between Phase 1 and Phase 3 results with the same organism/ antimicrobial agent pair (2, 10) .
The guidelines used for analyzing the susceptibility test results are shown in Table 2 . The minimal inhibitory concentration guidelines were jointly agreed upon by the collaborators prior to undertaking the study.
Discrepancies between the Autobac 1 results and the disk diffusion results were classified as "minor," "major" and "very major." A discrepancy was considered minor when an intermediate result was obtained by only one of the two methods. A discrepancy was major when the organism was found resistant by Autobac 1 and susceptible by the disk diffusion test. Conversely, a discrepancy was classified as very major when the organism was found susceptible by the Autobac 1 and resistant by the disk diffusion test. When the distinction between very major and major discrepancies was not made, discrepancies in these categories were classified collectively as "substantial." The same system was used for classifying discrepancies between Autobac 1 and the agar dilution test results, and between the disk diffusion and agar dilution test results.
RESULTS
The overall summary of results obtained with the three methods is shown in Tables 3 to 5 . Overall agreement between Autobac 1 and the disk diffusion test results was approximately 91% and ranged from 77 to 99%, with over 90% agreement for the majority of the organisms. The greatest number of discrepancies were minor and were apparent principally with nitrofurantoin, penicillin G, tetracycline (with gram-negative organisms), nalidixic acid, kanamycin, cephalothin, and carbenicillin. There were few major discrepancies (0.1 to 2.4%), but greater numbers of very major discrepancies (0 to 8.4%). The largest percentage of discrepancies was noted with nitrofurantoin, erythromycin, and cephalothin. As a result of this study, it was decided that tests of enterococci with cephalothin and P. aeruginosa with kanamycin were unreliable with Autobac 1. Because of limited therapeutic value of tests with these drug/ organism combinations, it was decided to contra-indicate the single species for each drug. When these data are excluded, the very major discrepancies with cephalothin were reduced from 7.5 to 2.4%, and for kanamycin from 4.5 to 0.4%.
When the Autobac 1 results from Phase 1 were compared to the Phase 2 International Collaborative Study agar dilution test results, the overall agreement was approximately 90% and ranged from 61 to 100%, with over 90% agreement for the majority of the organisms. Most of the discrepancies were minor, particularly with nitrofurantoin, ampicillin, cephalothin, carbenicillin (with P. aeruginosa), and tetracycline (with gram-negative organisms). There were few major discrepancies (0 to 5.2%), most of them with penicillin G. There were greater numbers of very major discrepancies (0 to 7.9%), the highest percentage being with kanamycin, tetracycline, and cephalothin. If P. aeruginosa is excluded from the kanamycin data, the number of very major discrepancies is reduced from 7.9 to 3.9%.
When bNumber of very major, major, minor discrepancies/total number of strains tested.
obtained with the Autobac 1. However, fewer very major discrepancies (O to 3.4%) were found between disk diffusion and agar dilution results than between Autobac 1 and agar dilution results (O to 8.4%).
A more detailed examination of the discrepancies by antimicrobial agent and by strain tested is shown in Tables 6 to 11 . The data in these tables show that in many instances one group of organisms caused most of the discrepancies for a given antimicrobial agent. For example, the majority of the very major discrepancies with ampicillin (Autobac 1 compared to the disk diffusion test) occurred with the Enterobacter species; the majority with cephalothin occurred with the enterococci (Table 7) .
Although Phase 3 of the collaborative study was designed primarily to provide comparative data on interlaboratory reproducibility of the Autobac 1 and disk diffusion methods, a measure of intralaboratory reproducibility as well as additional data on the interpretive equivalence between these two methods was obtained.
The estimated standard deviations (&), for both intra-and interlaboratory reproducibility, are listed in Table 12 . The results are given separately for gram-negative organisms and enterococci and for staphylococci; the ranges of VOL. 7, 1975 on " Number of very major, major, and minor discrepancies/ total number of strains tested. a reflect the different strains or antimicrobial agents within each category. The estimated standard deviations for the disk diffusion are very similar to those derived from results of repeated testing of the same strain.
Although the above estimated test variability is useful in predicting the relative reproducibility of the quantitative results (i.e., zone diameter or LSI) obtained with the test methods, it is of greater importance to determine if the interpretive results (susceptible, intermediate, or resistant) are reproduced by each method. A qualitative analysis of intralaboratory reproducibility was obtained by observing the frequency with which the Autobac 1 and the disk diffusion tests reproduced the same interpretative results when they were performed by the same collaborator on separate occasions. (Table 14) by grouping the data according to the number of collaborators agreeing on the same interpretive category. When the distribution of agreement among the five categories in Table 14 is tested by the Chi square test, no significant difference between the disk diffusion and the Autobac 1 methods can be demonstrated (P > 0.20). pairs tested by all seven collaborators by both tests (only six collaborators performed tests on colistin; therefore, this antimicrobial agent was eliminated from the equivalence studies). A total of 508 such test combinations were included in this analysis.
In more than two-thirds of the 508 tests performed by the seven investigators on the 70 isolates (67.5%), all seven collaborators agreed on a single interpretive category by both tests (Table 16) . However, at least five of the collaborators agreed on the same interpretive category by both tests 85.0% of the time (432 of 508 tests). In most of the remaining cases, five to seven of the collaborators agreed on an interpretive category by one of the two methods, while only one to four of the collaborators agreed on the same category by the remaining method. Failure of at least five of the seven collaborators to agree on an interpretive category by both methods occurred in only 1.2% of the tests. In 1% of the tests there was a major or very major discrepancy between the test method results, for example, when five or more collaborators agreed that the organism was resistant by one method, and five or more collaborators agreed it was susceptible by the other method (substantial disagreement, Table 16 ).
Quality control data were available from five of the seven collaborating laboratories for the E. coli and S. aureus reference strains. Control limits (95%) were established for each antimicrobial agent/control organism combination by applying twice the maximum acceptable standard deviation described by the National Committee for Clinical Laboratory Standards (7) to the mean inhibitory zone diameter determined by the collaborating investigators. No laboratory had individual test results outside the limits more frequently than would be expected.
DISCUSSION
These studies, which involved a total of 15,914 tests conducted with the Autobac 1 and the disk diffusion susceptibility methods, showed an overall agreement between the two procedures of approximately 90%. More than one-half the discrepancies were minor, i.e., one test recorded results in the intermediate category and the other recorded results in the susceptible or resistant categories. The majority of the remaining discrepancies involved organisms that were classified as resistant by the diffusion test and susceptible by the Autobac 1 test. A very closely similar pattern was seen when the Autobac 1 was compared with the dilution test. There was 90% agreement with 4.3% major and very major discrepancies. The overall agreement between the diffusion test procedure and the dilution method was 91%, with 2% major and very major discrepancies. Only with nitrofurantoin and ampicillin in the case of the Autobac 1 and with carbenicillin and nitrofurantoin in the case of the disk diffusion test were overall agreements less than 80%.
With certain organism/antimicrobial agent combinations, more frequent discrepancies were encountered between the agar dilution results and those obtained by the other tests. More than 10% of the results with Staphylococcus epidermidis tested against penicillin and tetracycline showed substantial discrepancies when the Autobac 1 data were compared with the agar dilution data. Similar results with tetracycline were obtained when the diffusion test was compared with the agar dilution test. The reasons for these discrepancies are not clear, but with penicillin such discrepancies were partly influenced by the restricted definition of minimal inhibitory concentration correlates of susceptibility that were selected for the study. A similar question of definition may account for the high incidence of very major dis- _. two particular organism/antimicrobial agent pairs if a single elution disk for each of these antimicrobial agents is used. As a result of these findings, and due to the limited therapeutic value of cephalothin for enterococcus infections and of kanamycin for Pseudomonas infections, the approach with cephalothin and kanamycin was to strive for good agreement with the other commonly isolated species (Tables 6 to 7 ) and to contra-indicate the single species in each instance. When these two instances of contraindication were included, an 85.4% agreement for cephalothin and an 86.7% agreement for kanamycin were obtained. Although a small increase in the incidence of minor discrepancies was affected by the inclusion of the contraindicated data, the principal change occurred in the incidences of very major discrepancies which increased from 2.4 and 0.4 to 7.5 and 4.5% with cephalothin and kanamycin, respectively.
A considerable improvement in the Autobac 1/disk diffusion agreement was achieved with penicillin G, but not with the other antimicrobial agents, if the R < 0.90 LSI interpretive guideline was used. A more accurate estimation of staphylococcal susceptibility to this antibiotic was possible when this guideline was used because it allowed a larger resistant LSI range for Staphylococcus strains which presumably exhibit various levels of penicillinase production in a 3-to 5-h incubation period.
Examination of the ampicillin results shows that the interpretative agreement was high and that incidences of substantial discrepancies were small for all of the species except Enterobacter. The principal source of disagreement between the two methods was the occurrence of susceptible Autobac 1 values for certain strains of the ampicillin-resistant population of Enterobacter sp. Two factors contributed to the large number of such discrepancies with Enterobacter and ampicillin. In many cases, there was growth in the cuvette, but it had settled to the bottom of the chamber in spite of continuous shaking. In such cases, the photometer read it as susceptible rather than resistant. This phenomenon also occurred to a lesser extent with Enterobacter and cephalothin. More recent studies at the University of Washington (Seattle) and at the Cleveland Clinic Foundation (Cleveland) have shown that the percentage of very major discrepancies can be approximately halved if the disk mass is kept within 80 to 125% of the nominal content, which was not the case in the study reported herein. Although there was still an average incidence of 15% very major discrepancies, these studies did not include visual observation for settled growth in the ampicillin chamber of the cuvette.
Similar results were obtained with nitrofurantoin and Proteus sp. The only significant incidences of very major discrepancies that were encountered with this agent were those found with both P. mirabilis and indole-positive VOL. 7, 1975 on October 25, 2017 by guest http://aac.asm.org/ Downloaded from AUTOMATED SUSCEPTIBILITY TESTING SYSTEM 479 regardless of the method employed. Substantial incidences of minor discrepancies were encountered with the Proteus populations, as well as with the Klebsiella sp. and Enterobacter sp. populations, and they reflect a general lack of agreement between any of the data obtained by the various susceptibility test methods used for these species with nitrofurantoin. The preponderance of intermediate interpretations obtained with all three methods, and particularly with the International Collaborative Study agar dilution method, will inevitably result in considerable lack of agreement in the interpretations rendered by any two susceptibility methods. The Autobac 1 and disk diffusion methods exhibited higher degrees of interpretative agreement than those obtained with the disk diffusion/agar dilution and Autobac 1/agar dilution comparisons.
When the Phase 3 data are considered, it should be noted that in the case of the disk diffusion method the width (in millimeters) of the intermediate interpretive zone is usually two or more times the standard deviation of repeated zone diameter measurements for a single organism, but in the case of the Autobac 1 the intermediate zone is equal to the overall estimated standard deviation of repeated measurements. Because of this relationship, it is more likely that substantial shifts in interpretation will occur on repeat testing of the same organism with the Autobac 1 ( Table 13) .
The Phase 3 data show that there is no significant difference between the Autobac 1 and disk diffusion tests in their ability to provide reproducibility of the interpretative category among the seven laboratories (Table  14) . However, when disagreements do occur, there is a significant difference in the distribution of these disagreements between the substantial and minor categories (Table 15) VOL. 7, 1975 on October 25, 2017 by guest http://aac.asm.org/ encountered when the dilution and diffusion techniques are performed in routine clinical work. Thus, when the Autobac 1 system is used in a large number of laboratories, agreement between its results and those of the other two tests will probably compare favorably with those obtained in this study.
Studies that have been made in two laboratories since this work was completed indicate that a tightening of the range of permissible variability of disk content for the Autobac 1 system substantially reduces the number of discrepancies with Proteus and nitrofurantoin and with Enterobacter and ampicillin. Further work and experience will probably lead to further improvements in performance in comparison to the other two tests.
Obviously, not all the potential problem areas could be investigated in a study such as this. For example, methicillin-resistant staphylococci and gentamicin-resistant P. aeruginosa strains are rare in this country, and thus these strains were in a minority in the study. Preliminary data suggest that some modifications in techniques may be needed to detect their resistance by the Autobac 1 system.
It should be noted that during the course of this study, the Autobac 1 system in the seven collaborative centers operated without malfunction and did not require any repairs or re-standardization. In addition, the manipulations and methodology used with the Autobac 1 system were easily learned and performed.
